La Brec, Matthew v. Murphy, James

District Court, W.D. Wisconsin·Decided October 23, 2023·No. 3:22-cv-00284·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF WISCONSIN

MATTHEW LA BREC,

Plaintiff, OPINION and ORDER v.

22-cv-284 jdp KRISTINE LYON and JAMES T. MURPHY,

Defendants.

Pro se plaintiff Matthew La Brec is suing medical staff for failing to provide him with adequate medical care at Columbia Correctional Institution. He originally named several defendants for failing to treat his chronic pain between 2020 and 2022. I dismissed some claims at the screening stage and La Brec has voluntarily dismissed other claims through settlement. Claims against two defendants remain. La Brec contends that Kristine Lyon (a nurse practitioner) failed to treat his pain in March 2021 and James T. Murphy (a physician) failed to treat his pain between April and June 2022, in violation of the Eighth Amendment and state common law. Each defendant has filed a separate motion for summary judgment. Dkt. 87 and Dkt. 97. I will grant Lyon’s motion and deny Murphy’s motion. Lyon is entitled to summary judgment because she offered La Brec treatment options, but he rejected them, and he doesn’t give a reason why. I will deny Murphy’s motion for summary judgment because a reasonable jury could find that he provided no treatment to La Brec other than over-the-counter medications that Murphy knew were not effective for La Brec, and he had no medical basis for declining to consider other treatment. That’s enough to support a claim for negligence and an Eighth Amendment violation. UNDISPUTED FACTS The following facts are undisputed. Lyon is an advanced practice nurse prescriber. Between October 2018 and December

2022, Lyon was a locum tenens nurse practitioner for the Wisconsin Department of Corrections. She worked at the Columbia prison beginning in March 2021. Murphy is a physician. He worked at the Columbia prison from October 2021 to July 2022. La Brec was a prisoner in the custody of the Wisconsin Department of Corrections during the events relevant to this case. Since 2015, La Brec has suffered from back pain. A March 2019 MRI showed a mild concentric disc bulge at L4-5, mild bilateral neural foraminal stenosis, and a small posterior broad-based disc bulge at L5-S1.

From 2018 to 2020, La Brec had a prescription for gabapentin while he was housed at the Wisconsin Resource Center, which is not governed by the Wisconsin Department of Corrections’ formulary restrictions. When La Brec was transferred to Columbia in August 2020, Justin Ribault, a physician, discontinued the gabapentin prescription because of La Brec’s history of substance abuse issues and because La Brec had a normal EMG study in 2018.1 Ribault prescribed duloxetine, acetaminophen, and ibuprofen instead. La Brec stopped taking duloxetine because of side effects, including a pounding heartbeat, headache, and blurry vision. Lyon examined La Brec in March 2021 in response to complaints of back pain that he described as an “achy, deep-seated pain.” La Brec asked Lyon for a gabapentin prescription.

1 The parties say little about La Brec’s past substance abuse. But I know from a previous case that La Brec was convicted of using methamphetamines in 2014. LaBrec v. Syed, 19-cv-804-jdp, 2023 WL 1927064, at *1 (W.D. Wis. Feb. 10, 2023). Gabapentin poses a risk for abuse and diversion, so DOC policy restricts its availability. For example, it may not be prescribed unless other medications have failed, an EMG has demonstrated that the prisoner has neuropathy, the prisoner has functional limitations because of nerve damage or pain, and the prisoner has no history of diverting medication. Lyon

determined that La Brec did not qualify for gabapentin under these restrictions because his description of pain was not consistent with nerve-related pain, his EMG result was normal, and there was no evidence of functional impairment. Lyon discussed other pain medications that La Brec could try, but La Brec refused any medication but gabapentin. Murphy began treating La Brec in November 2021. At the time, La Brec had prescriptions for acetaminophen, Extra-Strength Tylenol, and ibuprofen.2 During his first examination of La Brec on November 9, Murphy diagnosed La Brec with lumbar herniated disc with sciatica down the left leg and neuropathic pain. During this appointment, La Brec told

Murphy that Tylenol and ibuprofen were not effective for relieving his pain. Murphy increased the dose of La Brec’s prescription for ibuprofen and continued his prescription for acetaminophen and Extra-Strength Tylenol. Murphy also noted that La Brec was scheduled for another EMG. Depending on the results of the EMG, Murphy planned to submit an application to the medical director to treat La Brec’s pain with pregabalin.3

2 The parties don’t explain the difference between La Brec’s prescriptions for acetaminophen and Tylenol, but the progress notes state that the acetaminophen was for 250 milligrams and the Tylenol was for 500 milligrams. Dkt. 103-1, at 25. The parties also don’t explain why La Brec had both prescriptions. 3 Neither side explains what pregabalin is. The Mayo Clinic describes it as an anti-seizure medication that is also sometimes prescribed for nerve pain. It goes under the brand name Lyrica. Mayo Clinic, “Pregabalin,” available at https://www.mayoclinic.org/drugs- supplements/pregabalin-oral-route/side-effects/drg-20067411?p=1; see also Claypool v. Hamilton, No. 23-cv-343, 2023 WL 5748612, at *1 (E.D. Wis. Sept. 6, 2023) (describing Murphy examined La Brec three times in December 2021 to address complaints of low- back pain with left-sided radicular and neuropathic symptoms. During each of these appointments, La Brec told Murphy that Tylenol and ibuprofen were not effective for relieving his pain. Murphy did not make any changes to La Brec’s medication.

In February 2022, Murphy examined La Brec once for complaints of pain in his lower back and left leg. By then, Murphy had received La Brec’s EMG results. La Brec told Murphy that his pain was “severe,” that Tylenol and ibuprofen were not helping his pain, and that he needed something different. Murphy went over the EMG results with La Brec, but Murphy did not take any action based on the results. Murphy did not make changes to La Brec’s pain medication. In March 2022, Murphy examined La Brec for complaints of neuropathic pain radiating down his left leg from his back, among other things. La Brec told Murphy that Tylenol and

ibuprofen were not working. Murphy diagnosed La Brec with chronic degenerative joint disease and left radicular pain. Although the EMG results were normal, Murphy stated that he would apply for La Brec to receive pregabalin therapy. In his application, Murphy wrote that La Brec’s pain was a 7 out of 10, that the pain interfered with La Brec’s sleep, and that gabapentin had provided La Brec with relief in the past. On April 5, 2022, the medical director denied Murphy’s application for pregabalin, reasoning that La Brec’s EMG showed no abnormality and that he had a diagnosis for severe substance use disorder.

pregabalin as a treatment for nerve pain); Thomas v. Kijakazi, No. 21-cv-1385, 2023 WL 5279646, at *11 (E.D. Wis. Aug. 16, 2023) (same). On April 22, Murphy met with La Brec to discuss the denial of the application. Murphy diagnosed La Brec with chronic moderate low-back pain, but Murphy did not make any changes to La Brec’s pain medication. La Brec asked Murphy to resubmit an application for pregabalin that included a restriction for “crush and float,” meaning that La Brec’s pregabalin

Free access — add to your briefcase to read the full text and ask questions with AI

La Brec, Matthew v. Murphy, James, (W.D. Wis. 2023).

La Brec, Matthew v. Murphy, James (La Brec, Matthew v. Murphy, James) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Montgomery v. American Airlines, Inc.
626 F.3d 382 (Seventh Circuit, 2010)
Loudermilk v. Best Pallet Co., LLC
636 F.3d 312 (Seventh Circuit, 2011)
Yancick v. Hanna Steel Corp.
653 F.3d 532 (Seventh Circuit, 2011)
Gonzalez v. Feinerman
663 F.3d 311 (Seventh Circuit, 2011)
Forbes v. Edgar
112 F.3d 262 (Seventh Circuit, 1997)
Armond Norfleet v. Thomas Webster and Alejandro Hadded
439 F.3d 392 (Seventh Circuit, 2006)
Paul v. Skemp
2001 WI 42 (Wisconsin Supreme Court, 2001)
Gil v. Reed
535 F.3d 551 (Seventh Circuit, 2008)
Schuster v. Altenberg
424 N.W.2d 159 (Wisconsin Supreme Court, 1988)
Sawyer v. Midelfort
595 N.W.2d 423 (Wisconsin Supreme Court, 1999)
Ehlinger v. Sipes
454 N.W.2d 754 (Wisconsin Supreme Court, 1990)
Nathson Fields v. Lawrence Wharrie
740 F.3d 1107 (Seventh Circuit, 2014)
Miguel Perez v. James Fenoglio
792 F.3d 768 (Seventh Circuit, 2015)
Lloyd Johnson v. Karen Rimmer
936 F.3d 695 (Seventh Circuit, 2019)
George Walker v. Wexford Health Sources, Inc.
940 F.3d 954 (Seventh Circuit, 2019)